Results for 'OS'
Monty Pal
How Engineered Antibodies and Next Generation Imaging Tools are Reshaping Cancer Care with Anna Wu, Ph.D.
City of Hope, Monty Pal, Anna Wu, engineered antibodies, PET, imaging, radioisotope, CEA directed agent, PSCA targeted radiopharmaceutical, pancreatic cancer, prostate cancer
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Anna Wu, Ph.D., Chair of the Department of Immunology and Theranostics at City of Hope, joins host Monty Pal, M.D., for an engaging discussion on how innovations in antibody engineering and imaging are improving clinicians’…
Mar 9th • 42 mins listen
Jesus Izaguirre-Carbonell
Enhancing Cancer Treatment Decisions with Ultrasensitive MRD Testing
Quest Diagnostics, Jesus Izaguirre Carbonell, Thoman Slavin, MRD testing, minimal residual testing, precision tool, biomarker, ctDNA, circulating tumor DNA
Dr. Thomas Slavin breaks down how ultrasensitive MRD testing supports better cancer treatment decisions and enables earlier, more personalized interventions.
Jul 7th • 19 mins listen
Monty Pal
Three Leaders, One Vision: Principles for Transforming Cancer Care Delivery
City of Hope, Monty Pal, Walter Stadler, Alan Bryce, ASCO, national model, precision, AI, clinical trial design, dose strategy, early detection, long term survivorship
Dr. Walter Stadler & Dr. Alan Bryce share how City of Hope is building a national system for smarter research, greater access, and better cancer care.
Jun 23rd • 43 mins listen
Rebecca Previs
Why Genetic Testing Should Be Standard in Prostate Cancer
Labcorp, Rebecca Previs, Sarah Young, genetic counselor, genetic testing, prostate cancer, urologic oncology, germline, somatic, PARP inhibitors, digital
Hear why universal genetic testing matters in prostate cancer — plus, how it can improve treatment, equity, and outcomes for patients everywhere.
May 18th • 19 mins listen
Rebecca Previs
Tumor-Agnostic Therapies and the Future of HER2 in Oncology
Labcorp, Rebecca Previs, Heidi Ko, HER2, NGS, precision oncology, tumor agnostic, breast cancer, gastric cancer, biomarker, ERBB2, IHC, FISH, biomarker
What tumor-agnostic approvals mean for HER2, NGS, and precision oncology — and how they’re changing treatment across cancer types.
Jun 8th • 20 mins listen
Rebecca Previs
Why Comprehensive Testing Matters - Ken Schlosser’s Lung Cancer Story
Labcorp, Rebecca Previs, Ken Schlosser, biomarker, lung cancer, ALK+, advocacy, precision
Biomarker testing helped Ken Schlosser live with stage IV lung cancer for over 6 years. Here's how it shaped his care plan from the start.
Jul 31st • 23 mins listen
Rebecca Previs
Redefining Ovarian Cancer Care with Biomarkers
Labcorp, Rebecca Previs, Kyle Strickland, ovarian cancer, diagnosis, biomarker, HRD, RB1, tumor biology
Exploring ovarian cancer, biomarkers HRD & RB1, and how Labcorp innovations are advancing precision oncology.
Sep 7th • 14 mins listen
Rebecca Previs
FFPE: The Workhorse Behind NGS Testing
Labcorp, Rebecca Previs, Kyle Strickland, Erin Newburn, biomarker, sequencing, diagnostics, translational research, precision
Exploring FFPE’s impact on precision oncology, NGS innovation, and the future of tissue stewardship in cancer care with leading Labcorp experts.
Jan 28th • 33 mins listen
Rebecca Previs
Navigating the Future of CDXs in Oncology
Rebecca Previs, Dawn McHugh, Labcorp, precision oncology, companion diagnostics, CDx, biomarker, precision medicine
CDX expert Dawn McHugh joins Dr. Rebecca Previs to unpack the role of companion diagnostics in precision oncology and the future of cancer care.
Feb 18th • 26 mins listen
Monty Pal
Translating Discovery: Shaping Tomorrow’s Prostate Cancer Therapies
City of Hope, Monty Pal, Tanya Dorff, immunotherapy, prostate cancer, mentor
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Dr. Monty Pal welcomes Dr. Tanya Dorff, professor in the Department of Medical Oncology & Therapeutics Research and section chief of the Genitourinary Disease Program at City of Hope. Together they dive into Dorff’s pionee…
Nov 25th • 31 mins listen
Monty Pal
At the Crossroads of Cancer and Metabolism
City of Hope, Monty Pal, Charles Brenner, metabolism, diabetes, obesity, fatty liver, metabolic dysfunction, GLP-1, FGF21, NAD metabolism
Dr. Charles Brenner explores the metabolic links between cancer, diabetes, NAD, and the future of liver-focused therapies.
Jul 7th • 37 mins listen
Monty Pal
Asking the Impossible: How Bold Questions are Unlocking Diabetes Biggest Breakthroughs
City of Hope, Monty Pal, Alberto Pugliese, diabetes, microbiome, pancreas
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Dr. Monty Pal sits down with Dr. Alberto Pugliese, Samuel Rahbar Chair in Diabetes & Drug Discovery, chair of the Department of Diabetes Immunology and director of The Wanek Family Project for Type 1 Diabetes. Tune in to disc…
Nov 10th • 51 mins listen
Kirk Shepard
How Cross-Functional Teams Reshape Cancer Care
Jay Fine, Preclinical Research, Early Stage
In episode 3 of Oncology Voice Network Podcast, Dr. Kirk Shepard sits down with Dr. Jay Fine, a renowned immunologist and President of R&D at Evolve Immune Therapeutics and a Forbes-published author in Voices of Oncology, for a candid look at how discovery truly connects to patient care.
Feb 17th • 23 mins listen
Michael Pietrack
What are the most common behavioral-based job interview questions?
What are the most common behavioral-based job interview questions? Now that you know what #behavioralinterview #jobinterviews Questions sound like and how to use the #starmodel to answer them, you’re probably wondering what questions you’ll likely get. Well, today we’re goin…
Sep 10th • 4 mins listen
Kirk Shepard
Breakthroughs in Oncology Drug Development with Dr. Roy Baynes
How do world-changing cancer treatments go from concept to reality? Tune in and discover how strategy, leadership, and heart unite to change lives in oncology—listen now.
Mar 31st • 28 mins listen
Monty Pal
The Long Game of Cancer Genomics: John Carpten, Ph.D., on Building Precision Oncology that Reaches Patients
City of Hope, Monty Pal, John Carpten, genomics, genome mapping, TGen, Translational Genomics Research Institute, spatial biology, AI, access
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, John Carpten, Ph.D., Chief Scientific Officer at City of Hope, discusses the evolution of cancer genomics—how early genome mapping enabled today’s targeted approaches and what infrastructure and equity considerations will…
Mar 23rd • 56 mins listen
Kirk Shepard
The Power of Commercial Leadership in Oncology
Discover how commercial leadership, collaboration, and clear communication shape success in oncology—and why patients depend on it.
Mar 17th • 31 mins listen
Monty Pal
Unlocking the Future of Cancer Care: Precision Medicine, AI and the Patient Voice with Dr. Stacy Gray
City of Hope, Monty Pal, Stacy Gray, precision medicine, germline testing, INSPIRE program, whole body MRI, genomic, tumor board
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Stacy Gray, M.D., A.M., Director of Clinical and Scientific Strategy and Vice President of System Strategy at City of Hope, joins Monty Pal, M.D., F.A.S.C.O. in an engaging discussion of how precision medicine and AI are tran…
Feb 23rd • 43 mins listen
Kirk Shepard
Humans Beyond the Algorithm: Hiring for Oncology’s Future
Stacy Benefiel, AI, Talent, Workforce Innovation, Human Resources, HR
In episode 4 of Oncology Voice Network Podcast, Host Dr. Kirk Shepard welcomes Stacey Benefiel, PharmD, Head of Global Clinical and Medical Affairs at Canopy, for a candid exploration of what it really takes to build the future oncology workforce.
Mar 3rd • 23 mins listen
Monty Pal
Pushing the Limits of Cancer Research and Surgery
City of Hope, Monty Pal, Mustafa Raoof, PIPAC, peritoneal, pancreatic cancer, surgical oncology
Dr. Mustafa Raoof on PIPAC, pancreatic cancer research, and how global innovation can shape the next chapter of surgical oncology.
Apr 7th • 38 mins listen